AVAI Bio, Inc. (AVAI) stock
Close on Oct 19, 2026Market cap $17.24MP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $17.24M
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$2.79M
- EPS, diluted
- $0.00
- Book value per share
- -$0.02
- Diluted shares
- 154M
Trading
- Previous close
- $0.11
- Open
- $0.11
- Day's range
- $0.11 – $0.11
- Volume
- 25,000
- Average volume (20 days)
- 77,140
Market cap history
Month-end market cap since 2020, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | AVAI | S&P 500 | Difference | AVAI per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -30.0% | +0.6% | −30.6 pts | ||
| 3 months | -25.2% | +3.4% | −28.6 pts | ||
| Year to date | -70.5% | +13.3% | −83.8 pts | ||
| 1 year | -65.0% | +16.6% | −81.6 pts | ||
| 3 years | -88.8% | +86.4% | −175.2 pts | -51.8% | +23.1% |
| 5 years | -92.8% | +81.9% | −174.6 pts | -40.9% | +12.7% |
Nine years at a glance
Fiscal years 2018 to 2026 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Press releases
Releases AVAI Bio filed with the SEC as exhibits to Form 8-K or 6-K
About AVAI Bio
Services-Computer Processing & Data Preparation
Avai Bio, Inc. develops and commercializes artificial intelligence solutions and provides information technology consulting services. The company focuses on machine learning systems and data integration, database management, and cloud services. Its primary technology assets include Avant! AI, an unsupervised and supervised learning model designed for data processing and reasoning, and Instant Fame, a platform facilitating digital art ratings and auctions. Additionally, the company offers Thy News, a mobile application that aggregates news feeds from various publishers for individual consumers. Through these offerings, Avai Bio serves enterprise organizations seeking artificial intelligence capabilities and end users of its digital media platforms.
Company profile, executives and historyAVAI Bio stock: common questions
What is AVAI Bio's stock price?
AVAI closed at $0.11 on Oct 19, 2026, down 1.75% on the day.
What is AVAI Bio's market cap?
AVAI Bio was worth $17.24M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.
What is AVAI's P/E ratio?
AVAI Bio lost money over the twelve months to Jun 30, 2026 (diluted EPS $0.00), so it has no meaningful P/E ratio.
Does AVAI Bio pay a dividend?
No. AVAI Bio has not paid a cash dividend over the last twelve months.
How has AVAI stock performed over the past year?
Including dividends, AVAI returned -65.0% over the past year, against +16.6% for the S&P 500.
Who are AVAI Bio's competitors?
Companies most similar to AVAI Bio by business, industry and size include ELVX, VERI, INOD, RADC, SHAZ.
See a number that looks wrong?